The DOI matches its Crossref record; 320 of the 339 references it cites were found in a registry or an index; none of the 253 sources its claims cite is checked for support yet.
Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
Open accessAbstract
Melatonin has become a popular dietary supplement, most known as a chronobiotic, and for establishing healthy sleep. Research over the last decade into cancer, Alzheimer’s disease, multiple sclerosis, fertility, PCOS, and many other conditions, combined with the COVID-19 pandemic, has led to greater awareness of melatonin because of its ability to act as a potent antioxidant, immune-active agent, and mitochondrial regulator. There are distinct similarities between melatonin and vitamin D in the depth and breadth of their impact on health. Both act as hormones, affect multiple systems through their immune-modulating, anti-inflammatory functions, are found in the skin, and are responsive to sunlight and darkness. In fact, there may be similarities between the widespread concern about vitamin D deficiency as a “sunlight deficiency” and reduced melatonin secretion as a result of “darkness deficiency” from overexposure to artificial blue light. The trend toward greater use of melatonin supplements has resulted in concern about its safety, especially higher doses, long-term use, and application in certain populations (e.g., children). This review aims to evaluate the recent data on melatonin’s mechanisms, its clinical uses beyond sleep, safety concerns, and a thorough summary of therapeutic considerations concerning dietary supplementation, including the different formats available (animal, synthetic, and phytomelatonin), dosing, timing, contraindications, and nutrient combinations.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review argues melatonin resembles vitamin D as a pleiotropic, light/dark-responsive hormone and reviews its mechanisms, clinical uses beyond sleep, safety, and supplement considerations. It emphasizes that melatonin is not simply a sleep aid, that dosing should generally be low and personalized, and that phytomelatonin may outperform synthetic melatonin in some in vitro assays.
Key findings
- The pineal gland produces about 0.1–0.9 mg melatonin daily, while gut enterochromaffin cells contain roughly 400 times more melatonin than the pineal gland, with gut levels 10–100 times greater than serum levels; production declines with age.
- In vitro, phytomelatonin showed 646% stronger COX-2 inhibition, 267–470% more potent free-radical scavenging, and 100% greater efficacy in reducing cellular ROS in a human skin cell line compared with synthetic melatonin.
- Clinical studies cited include 3 mg melatonin reducing migraine frequency comparably to amitriptyline; 10 mg nightly reducing endometriosis pain by about 40% and pain-medication use by 80%; six months of melatonin in PCOS decreasing androgens, free testosterone, hydroxyprogesterone, anti-Mullerian hormone, and LDL, with menstrual irregularities decreasing in 95%; and controlled-release melatonin reducing asleep systolic blood pressure by 3.57 mm Hg.
- Supplement quality and safety concerns include 31 over-the-counter melatonin products ranging from −83% to +478% of label claim, limited safety studies for high-dose melatonin (≥10 mg/day), and evidence that 0.3 mg restored sleep efficiency without the hypothermia and daytime melatonin elevation seen with 3 mg.
Methods
- Narrative review; no systematic search strategy or review protocol is reported.
- It synthesizes mechanistic, preclinical, and clinical literature on melatonin mechanisms, clinical uses, safety, dietary sources, supplement formats, dosing, timing, contraindications, and nutrient combinations.
- Evidence discussed includes in vitro cellular assays, animal studies, randomized controlled trials, meta-analyses, systematic reviews, cohort studies, and clinical guidelines; no new primary data are presented.
Limitations
- Stated: there are limited studies to conclude safety of high-dose melatonin (≥10 mg/day); there is a lack of significant data on nutrient combinations; bioavailability of different formats and sources remains unanswered; and in the bone-health combination trial, melatonin cannot be inferred to be responsible for the effects.
- Stated/evident: several clinical areas rely on small, older, or mixed studies—for example, endometriosis results are mixed, shift-work findings are inconsistent or show essentially no benefit, and most jet-lag dosing research is 10–20 years old or older.
- Evident: as a narrative review without systematic search or risk-of-bias assessment, selection and interpretation may be subject to bias; laboratory assessment of melatonin is also confounded by light exposure, timing, diet, season, physical activity, age, sex, genetics, and posture.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 253 cited sources checked · 0 supported · 0 flagged
In the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In one of the studies, Akkermansia muciniphila and Lactobacilli species were increased in the melatonin-treated animals [46].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [46] Park, 2020, Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation, Intest Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Both doses of melatonin taken in the morning, approximately 6 h after the sleep midpoint, will cause a phase delay.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“For instance, 0.5 mg and 3.0 mg of melatonin taken eleven hours before the sleep midpoint will cause a phase advance, so the individual feels sleepy earlier and awakens earlier.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Trials that used higher doses of melatonin and conducted over a longer duration demonstrated even greater effects on these two sleep issues, and overall sleep quality was also significantly improved in melatonin users [1,91].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Both doses improved sleep efficiency, but the higher dose impacted the biological day and night sleep patterns, the duration of non-REM sleep, and awakening time [93].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [93] Duffy, 2022, High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“A meta-analysis of melatonin for the treatment of primary sleep disorders analyzed nineteen studies involving 1683 individuals.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In 2022, researchers at Harvard Medical School and Brigham and Women’s Hospital explored low (0.3 mg) and high (5 mg) dose melatonin in a relatively small sample of healthy older adults.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [93] Duffy, 2022, High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults, J. Pineal Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- It may state two separate claims as one. 90
- Probably not a substantial claim. 46
- The quote only partly states this claim. 1
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Of note, when melatonin is taken 4 h before the sleep midpoint, i.e., at bedtime, the low dose of 0.5 mg does not shift the circadian rhythm, while the 3.0 mg dose will cause a phase delay.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Both doses improved sleep efficiency, but the higher dose impacted the biological day and night sleep patterns, the duration of non-REM sleep, and awakening time [93].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [93] Duffy, 2022, High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“A randomized study of people with delayed sleep-wake phase disorder found that a low dose of melatonin (0.5 mg) an hour before the desired bedtime, along with behavioral strategies for four weeks, resulted in earlier sleep onset, improved sleep efficiency during the first third of the night, and reduced subjective complaints [72].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [72] Sletten, T.L., Magee, M., Murray, J.M., Gordon, C.J., Lovato, N., Kennaway, D.J., Gwini, S.M., Bartlett, D.J., Lockley, S.W., and Lack, L.C. (2018). Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial. PLoS Med., 15. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“A 2017 systematic review [92] identified 5030 studies on melatonin and sleep, but only twelve were included to meet their criteria for randomized, controlled, and single or double-blind studies.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [92] Auld, 2017, Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders, Sleep Med. Rev. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin had a statistically significant effect on reducing sleep latency and increasing total sleep time.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In a Cochrane review, nine out of ten trials found that melatonin effectively reduced jet lag symptoms in travelers, especially if traveling eastward or over five time zones [74].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [74] Herxheimer, 2002, Melatonin for the prevention and treatment of jet lag, Cochrane Database Syst. Rev.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In a small pilot study of elderly patients with a mild cognitive deficit, the ability to remember previously learned items improved, and depression decreased with melatonin [105].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [105] Zizi, 1998, Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Levels from infancy to adolescence increase and plateau in association with Tanner stages of puberty and then slowly decline with age starting in the late twenties [9,10].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“From a basic mechanistic perspective, both have widespread effects on multiple systems and are found extensively throughout the body.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
In the paper
“Breastfed babies have the benefit of melatonin from their mother’s milk [8].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [8] Caba, 2022, Breast Milk and the Importance of Chrononutrition, Front. Nutr. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Both act as hormones, affect multiple systems through their immune-modulating, anti-inflammatory functions, are found in the skin, and are responsive to sunlight and darkness.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Like vitamin D, melatonin could plausibly be treated as a required dietary nutrient, with certain individuals necessitating less, more, or fine-tuning to personalized needs for lifestyle requirements (e.g., exposure to artificial blue light at night, jet lag, shift work) or alterations in physiology, such as gene variants in melatonin receptors or metabolic response [2,3].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [2] Celestin, 2021, Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States, J. Pharm. Sci. source
- Not checked yetcites [3] Garaulet, 2015, Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans, Metabolism source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“On average, the pineal gland produces between 0.1 and 0.9 mg of melatonin per day [4,6].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin production and circadian rhythms do not develop in babies until around three months [7].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [7] Rivkees, 1997, Developing circadian rhythmicity. Basic and clinical aspects, Pediatr. Clin. N. Am. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In fact, there may be similarities between the widespread concern about vitamin D deficiency as a “sunlight deficiency” and reduced melatonin secretion as a result of “darkness deficiency” from overexposure to artificial blue light.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > Abstract
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Ultraviolet (UV)-B radiation is required to convert 7-dehydrocholesterol in the skin to vitamin D3 [21].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [21] Wacker, 2013, Sunlight and Vitamin D: A global perspective for health, Dermato-Endocrinology source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specifically, vitamin D and melatonin may work synergistically in the skin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Its synthesis is reduced by exposure to light, with artificial light reducing a person’s melatonin production and increasing disease risk [4,6].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“It has been proposed that both vitamin D and melatonin orchestrate many of their functions, especially related to redox status, at the level of the mitochondria [27].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [27] Ferder, 2020, Daily and seasonal mitochondrial protection: Unraveling common possible mechanisms involving vitamin D and melatonin, J. Steroid Biochem. Mol. Biol. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Numerous studies have identified melatonin as a powerful free-radical scavenger with potential protective properties against neurodegenerative disorders, epilepsy, and certain cancers.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Concurrent with the age-related depletions in levels of vitamin D and melatonin, there is mitochondrial dysfunction, which has implications in a variety of clinical conditions that present differently through the seasons with changing light exposure [27].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [27] Ferder, 2020, Daily and seasonal mitochondrial protection: Unraveling common possible mechanisms involving vitamin D and melatonin, J. Steroid Biochem. Mol. Biol. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Newer, in vitro data on phytomelatonin would suggest superior antioxidant, anti-radical, and anti-inflammatory effects over synthetic melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Finally, melatonin is involved with multiple activities that include mitochondrial homeostasis, genomic regulation, modulation of inflammatory and immune cytokines, directly impacting both systemic and acute anti-inflammatory properties as well as indications around its potential role in phase separation [25,26].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [25] Tan, 2015, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules source
- Not checked yetcites [26] Loh, D., and Reiter, R.J. (2021). Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. Antioxidants, 10. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin’s dual actions can inhibit pro-oxidative enzymes (e.g., xanthine oxidase) while also acting to potentiate the critical antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase, and catalase, aiding in the body’s first line of immune defense and metabolic detoxification [31,32].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [31] Ighodaro, 2018, First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid, Alex. J. Med.
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Of interest, research has indicated that the sheer amplitude of plasma melatonin may not have as much to do with chronological age but more with the degree of pineal calcification and associated melatonin secretion [16].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [16] Tan, D.X., Xu, B., Zhou, X., and Reiter, R.J. (2018). Pineal Calcification, Melatonin Production, Aging, Associated Health Consequences and Rejuvenation of the Pineal Gland. Molecules, 23. source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin assists in mitochondrial redox balance through its ability to reduce the superoxide anion molecule from the electron transport chain and to directly scavenge free radicals [36].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [36] Reiter, R.J., Tan, D.X., Rosales-Corral, S., Galano, A., Zhou, X.J., and Xu, B. (2018). Mitochondria: Central Organelles for Melatonin’s Antioxidant and Anti-Aging Actions. Molecules, 23. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The established serotonergic and melatonergic systems may be vulnerable before establishing a stable global biota in infancy.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“It can stimulate the regeneration of epithelial cells [43] and has also been shown to have protective antioxidant effects on the lining of the GI tract [43].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [43] Kanova, M., and Kohout, P. (2021). Tryptophan: A Unique Role in the Critically Ill. Int. J. Mol. Sci., 22. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It is suspected that the gut-brain axis is a network of complex interactions between the nervous and GI systems with major contributions from intestinal microbiota.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Unlike pinealocytes, enterochromaffin cells are not regulated by light and dark but appear affected by food intake and digestion [39,40].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [39] Rezzani, R., Franco, C., Franceschetti, L., Gianò, M., and Favero, G. (2022). A Focus on Enterochromaffin Cells among the Enteroendocrine Cells: Localization, Morphology, and Role. Int. J. Mol. Sci., 23. source
- Not checked yetcites [40] Yasmin, 2021, Gut melatonin: A potent candidate in the diversified journey of melatonin research, Gen. Comp. Endocrinol. source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Low levels of melatonin may trigger an upregulation in the kynurenine pathway, and kynurenine production, as well as trigger the aryl hydrocarbon receptor (AhR) located on the outer membrane of the mitochondria [32,55,56,57,58].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
- Not checked yetcites [57] Reiter, 2010, Neurotoxins: Free radical mechanisms and melatonin protection, Curr. Neuropharmacol. source
- Not checked yetcites [58] Brinkmann, 2019, The Aryl Hydrocarbon Receptor (AhR) in the Aging Process: Another Puzzling Role for This Highly Conserved Transcription Factor, Front. Physiol. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Levels of melatonin are known to be higher in mitochondria compared with blood levels, most likely due to the greater antioxidant requirements with the copious amounts of free radicals generated through the electron transport chain [25].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [25] Tan, 2015, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Elderly individuals may also be more susceptible to serotonergic and melatonergic system errors due to known lower amounts of biota diversity.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The release of melatonin in the gut acts in a paracrine manner to increase activity and circulation in the gastric mucosa and enhances GI motility [5,41].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [5] Chen, 2011, Distribution, function and physiological role of melatonin in the lower gut, World J. Gastroenterol. source
- Not checked yetcites [41] Fowler, 2022, Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions, Front. Neurosci. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ultimately, the gut microbiota may influence CNS function and, over time, could cause neurological diseases, including Alzheimer’s disease, mood and anxiety disorders, multiple sclerosis (MS), Parkinson’s disease, and migraines.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It may be that declining melatonin levels with age and, thus, less protection of the mitochondria from oxidative stress may be contributors to preclinical changes and, ultimately clinical symptoms.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin is derived from serotonin using 5-hydroxytryptophan (5-HTP) and tryptophan [32,55].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Quinolinic acid is a neurotoxin, while kynurenic acid has neuroprotective properties [32,55,56,57,58].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
- Not checked yetcites [57] Reiter, 2010, Neurotoxins: Free radical mechanisms and melatonin protection, Curr. Neuropharmacol. source
- Not checked yetcites [58] Brinkmann, 2019, The Aryl Hydrocarbon Receptor (AhR) in the Aging Process: Another Puzzling Role for This Highly Conserved Transcription Factor, Front. Physiol. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Circadian rhythm sleep-wake disorders are either intrinsic or extrinsic.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Many neurological disorders feature elements of the kynurenine pathway of tryptophan, specifically the dysregulation of tryptophan metabolism and subsequent melatonin production.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This dosing regimen may contribute to the occasional complaints of a paradoxical effect of melatonin supplements on sleep.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin is both water- and lipid-soluble (‘amphiphilic’); thereby, it can freely flow among all bodily tissues, especially across the selective blood–brain barrier, making it likely one of the most formidable antioxidants within the central nervous system [60].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [60] Escames, 2010, The role of mitochondria in brain aging and the effects of melatonin, Curr. Neuropharmacol. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Melatonin supplements can be used therapeutically for both conditions [67].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [67] Auger, 2015, Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline, J. Clin. Sleep Med. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Studies using melatonin have explored how shift work, particularly night work with its exposure to light at night, may increase the risk of cancer, aggravate both gastrointestinal and cardiovascular disease, complicate pregnancy, and interfere with drug therapy [68].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [68] Iguichi, 1982, Age-dependent reduction in serum melatonin concentrations in healthy human subjects, J. Clin. Endocrinol. Metab. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The AhR is responsible for modulating mitochondrial metabolism, melatonergic pathways, acetyl-coenzyme A, and COX-2 prostaglandin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The melatonin-serotonin pathway accounts for approximately five percent of dietary tryptophan degradation, while the kynurenic pathway accounts for approximately 95 percent of dietary tryptophan degradation [32,56].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“The summary concluded that melatonin is indicated for the following [92]:Insomnia: Immediate release 1–3 mg, 30 min before bed; slow-release can be used for sleep maintenance problemsRegulating sleep in blind individuals who often experience non-24 h sleep-wake rhythm disorder;Replicating the normal endogenous pattern;Delayed sleep phase.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [92] Auld, 2017, Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders, Sleep Med. Rev. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Dysfunctional sleep does not have one mechanism, such as reduced melatonin, but potentially several causes, some or all, may be impacting melatonin levels.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Relatively smaller amounts of melatonin are produced in the retina compared with the pineal gland [96].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [96] Ostrin, 2019, Ocular and systemic melatonin and the influence of light exposure, Clin. Exp. Optom. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Importantly, iRBD is a prodrome biomarker for Parkinson’s disease.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, at a larger, more macroscopic level, as mentioned previously, imbalances in melatonin may be associated with what might be referred to as a “darkness deficiency,” or a lack of adequate evening darkness to initiate the secretion of melatonin by the pineal gland.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“However, interest has been expressed for inflammatory conditions such as ocular neuritis and uveitis [97].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [97] Aranda, 2017, Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases, Curr. Neuropharmacol. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Many studies support melatonin’s use in reducing the ill effects of jet lag and speeding up the normalization of circadian rhythms [73].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [73] Srinivasan, 2008, Jet lag: Therapeutic use of melatonin and possible application of melatonin analogs, Travel. Med. Infect. Dis. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Patients with iRBD will retain muscle tone during REM sleep and can act out their dreams, posing a danger to themselves and others.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Moreover, there may be an association between environmental toxins such as heavy metals (e.g., arsenic) and sleep disturbance [82,83].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [82] Rahman, 2022, Association of urinary arsenic and sleep disorder in the US population: NHANES 2015-2016, Environ. Sci. Pollut. Res. Int. source
- Not checked yetcites [83] Shiue, 2017, Urinary arsenic, pesticides, heavy metals, phthalates, polyaromatic hydrocarbons, and polyfluoroalkyl compounds are associated with sleep troubles in adults: USA NHANES, 2005-2006, Environ. Sci. Pollut. Res. Int. source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Some researchers suggest that glaucoma may be a therapeutic target for melatonin [98,99].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [98] Martínez-Águila, A., Martín-Gil, A., Carpena-Torres, C., Pastrana, C., and Carracedo, G. (2021). Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma. Biomolecules, 11. source
- Not checked yetcites [99] Gubin, 2022, Melatonin, circadian rhythms and glaucoma: Current perspective, Neural Regen. Res. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Overall, children diagnosed with ASD and positive family history had higher serum melatonin and nitric oxide levels, with significantly lower malondialdehyde/melatonin ratios, suggesting greater impaired oxidant-antioxidant metabolism and balance in children with ASD [117].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [117] Rana, 2021, The Assessment and Treatment of Sleep Abnormalities in Children and Adolescents with Autism Spectrum Disorder: A Review, J. Can. Acad. Child Adolesc. Psychiatry
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Overall, clinical data suggest that melatonin supplementation improves sleep and neurotransmission and reduces sundowning in those with Alzheimer’s disease.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In a systematic review and meta-analysis of thirteen clinical trials, melatonin supplementation was found to decrease inflammatory compounds (TNF-alpha, IL-6, C-reactive protein), although with a more significant lowering effect on TNF-alpha and IL-6, especially with studies ≥ twelve weeks and at a dosage ≥ 10 mg/day [175].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.5. (Auto)Immunity
What the sources say
- Not checked yetcites [175] Zarezadeh, 2020, Melatonin supplementation and pro-inflammatory mediators: A systematic review and meta-analysis of clinical trials, Eur. J. Nutr. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Moreover, with the indole structure of melatonin closely resembling that of tryptophan, there could be theoretical safety concerns related to the Eosinophilia-Myalgia Syndrome (EMS) outbreak in 1989 from the intake of at least six contaminants in an L-tryptophan dietary supplement [264,265,266], although the dose of melatonin tends to be about 1000 times lower than that of tryptophan.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [264] Williamson, 1997, Contaminants in commercial preparations of melatonin, Mayo Clin. Proc. source
- Not checked yetcites [265] Williamson, 1998, Structural characterization of contaminants found in commercial preparations of melatonin: Similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome, Chem. Res. Toxicol. source
- Not checked yetcites [266] Allen, 2011, Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan, Arthritis Rheum. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“It was found that autistic patients have low melatonin levels caused by a primary deficit in ASMT gene activity [116].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [116] Melke, 2008, Abnormal melatonin synthesis in autism spectrum disorders, Mol. Psychiatry source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Age-related macular degeneration is another serious ophthalmic condition that theoretically could benefit from melatonin administration, although significant clinical research is currently lacking [100,101].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [100] Rastmanesh, 2011, Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity, Med. Hypotheses source
- Not checked yetcites [101] Mehrzadi, 2020, Mitochondrial dysfunction in age-related macular degeneration: Melatonin as a potential treatment, Expert Opin. Ther. Targets source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Most notable is early research conducted on patients with solid metastatic tumors, in which it was demonstrated that high doses of melatonin were effective in arresting tumor growth and improving quality of life markers [178].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.5. (Auto)Immunity
What the sources say
- Not checked yetcites [178] Lissoni, 1991, Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies, Oncology source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“At a mechanistic level, it may decrease the progression of the disease through its protection of neuronal cells from amyloid-beta, possibly due to the facilitation of its degradation and transport from the brain matter through the glymphatic fluid [102,103,104].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [102] Lin, 2013, Melatonin in Alzheimer’s disease, Int. J. Mol. Sci. source
- Not checked yetcites [103] Roy, J., Tsui, K.C., Ng, J., Fung, M.L., and Lim, L.W. (2021). Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease. Int. J. Mol. Sci., 22. source
- Not checked yetcites [104] Li, 2020, Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease, Biomed. Pharmacother. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Migraines can also be correlated with many autoimmune disorders tied to melatonin regulation failure. These conditions include Hashimoto’s thyroiditis with associated hypothyroidism, rheumatic diseases, and antiphospholipid syndrome [109].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [109] Ribeiro, 2016, Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention, J. Neurol. Neurosurg. Psychiatry source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Migraine headaches are comorbid with several health conditions, including neurological, psychiatric, cardiovascular, cerebrovascular, GI, metaboloendocrine, and immunological disorders.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A review article found that patients with autism had improved sleep parameters, better daytime behavior, and minimal side effects with melatonin use [118].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [118] Rossignol, 2011, Melatonin in autism spectrum disorders: A systematic review and meta-analysis, Dev. Med. Child. Neurol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For jet lag, recent studies are lacking in detailing the most efficacious dose.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin may not be effective for everyone but could be well-suited for those individuals with a history of jet lag and/or for those flying across ≥ five time zones to the East [74].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [74] Herxheimer, 2002, Melatonin for the prevention and treatment of jet lag, Cochrane Database Syst. Rev.
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Melatonin may not be effective for everyone.
In the paper
“There have also been reports of vivid dreams or nightmares while using melatonin supplements [164].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [164] Siah, 2014, Melatonin for the treatment of irritable bowel syndrome, World J. Gastroenterol. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Interestingly, the control group (not insomniacs) also had low melatonin levels, but melatonin did not improve sleep.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“They concluded that that too much melatonin may negatively affect the melatonin phase-response curve [281].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [281] Lewy, 2002, Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period, Chronobiol. Int. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Some studies used a protocol in which melatonin supplementation was initiated three days before travel started [284,285].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The pharmacological dose (3 mg), like the lowest dose (0.1 mg), also improved sleep; however, it induced hypothermia and caused plasma melatonin to remain elevated into the daylight hours.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Much has been written about melatonin’s therapeutic value, but the doses used in studies tended to be supraphysiological or based on previous studies that did not have an explicit rationale for choosing the amount.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“The dose of melatonin was patented up to 1 mg based on this earlier research [279], excluding dietary supplement manufacturers from selling this dose and thus, using higher doses.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [279] (1995). National Center for Biotechnology Information. Methods of Inducing Sleep Using Melatonin. (US5449683A), U.S. Patent.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Melatonin’s action of lowering body temperature is important to monitor and may give significant clues to the appropriate dosage.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In clinical applications, too much melatonin or various extended-release formats have been documented to produce side effects such as amnesia or a “melatonin hangover” the next day, finding it harder to fall asleep, or sleeping well for three to four hours and then waking up and not being able to go back to sleep [275].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [275] Benedict, 2022, Melatonin’s Potential Side Effects: It May Be in Your Genes, Mayo Clin. Proc. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The physiological dose (0.3 mg) restored sleep efficiency and elevated plasma melatonin levels to normal during early adulthood.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Although more research is needed comparing synthetic and plant-based sources of melatonin, there is some initial indication that phytomelatonin may have advantages related to improved bioavailability and efficacy.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
- Not checked yetcites [267] Pérez-Llamas, F., Hernández-Ruiz, J., Cuesta, A., Zamora, S., and Arnao, M.B. (2020). Development of a Phytomelatonin-Rich Extract from Cultured Plants with Excellent Biochemical and Functional Properties as an Alternative to Synthetic Melatonin. Antioxidants, 9. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While a theoretical concern, there is a lack of significant scientific evidence that this dependence can develop, and if it does, under which conditions and individuals may be most susceptible.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Lissoni et al.’s cancer research from over twenty years ago demonstrated that 20 mg given intramuscularly followed by oral daily doses of 10 mg was effective in arresting tumor growth and improving quality of life markers [178].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [178] Lissoni, 1991, Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies, Oncology source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This pharmaceutical is a known inhibitor of CYP1A2 and can result in the potentiation of melatonin levels due to reducing its degradation [304].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [304] Wang, 2001, Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin, J. Clin. Psychopharmacol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In summary, while not a comprehensive listing, melatonin can interact or be influenced by pharmaceuticals, nutrients, or herbs with blood thinning, blood sugar-lowering, blood pressure reducing, anti-convulsing, sedative, anti-depressant, and/or immunosuppressive activities [306].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [306] Therapeutic Research (2022, July 31). Melatonin. Available online: https://naturalmedicines.therapeuticresearch.com/.
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“A few human clinical studies published more than two decades ago would suggest that vitamin B12 supplementation increased the phase advance effect of morning light and decreased nocturnal melatonin levels [309,310]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [309] Honma, 1992, Effects of vitamin B12 on plasma melatonin rhythm in humans: Increased light sensitivity phase-advances the circadian clock?, Experientia source
- Not checked yetcites [310] Hashimoto, 1996, Vitamin B12 enhances the phase-response of circadian melatonin rhythm to a single bright light exposure in humans, Neurosci. Lett. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Neither the parents nor children monitored their melatonin use but relied on the initial study proposal, so dosing varied widely.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As stated above, combining melatonin supplementation with actives that influence melatonin pharmacokinetics may cause side effects.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“In one report, clinicians observed that the initial response to melatonin had disappeared weeks after starting treatment, and that the favorable response returned with dose reduction [293].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [293] Braam, 2010, Loss of response to melatonin treatment is associated with slow melatonin metabolism, J. Intellect. Disabil. Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Historically, much of the research related to sleep has indicated melatonin supplementation thirty to sixty minutes before bed; yet, some studies have shown that it can be taken up to four hours prior and be effective.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.4. Timing
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In an average of 3.7 years of follow-up from previous clinical trial participation of pharmacological doses of melatonin, 65% of children were still using melatonin as prescribed in the study, but only 9% were able to discontinue use [290].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Compliance nearly four years later was at 65%, presumably due to the satisfaction of use.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Only one questionnaire-based study investigated long-term melatonin use in children with ADHD and chronic insomnia and, by its design, was based on subjective symptom reports.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Lewy suggests that dosing for sleep requires a minimum of twelve hours of wakefulness [281].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.4. Timing
What the sources say
- Not checked yetcites [281] Lewy, 2002, Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period, Chronobiol. Int. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The authors would like to emphasize that the dramatic increase in the use of supplemental melatonin in children is unwarranted because they endogenously produce more melatonin than adults [10].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [10] Grivas, 2007, Melatonin the “light of night” in human biology and adolescent idiopathic scoliosis, Scoliosis source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“It is well accepted that melatonin in tablet or capsule form is generally not very bioavailable (1 to 74%) and can be influenced by multiple variables [295].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [295] Savage, R.A., Zafar, N., Yohannan, S., and Miller, J.M.M. (2022). Melatonin. StatPearls, StatPearls Publishing LLC.. StatPearls Publishing. Copyright © 2022.
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“From a pharmacokinetic standpoint, Vasey, McBride, and Penta [297] indicated that melatonin administered in tablet or capsule forms follows first-order or concentration-dependent kinetics. This implies that the kinetic absorption of melatonin is, in fact, not saturable, meaning that larger doses would produce higher plasma concentrations.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [297] Vasey, C., McBride, J., and Penta, K. (2021). Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin. Nutrients, 13. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Dyssomnia, ADHD, and ASD have been studied and reviewed, all confirming effectiveness and safety of melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one. The quote only partly states this claim.
In the paper
“Oral melatonin has been studied to reach peak plasma concentration after forty-one minutes of administration, although it was reported that melatonin pharmacokinetics varied greatly between individuals [297].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [297] Vasey, C., McBride, J., and Penta, K. (2021). Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin. Nutrients, 13. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“A systematic review by researchers at the University of Copenhagen cited an average of 15% bioavailability from oral melatonin, which was highly variable (range: 9–33%) and affected by age, illness, caffeine, smoking, and medications [296].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [296] Andersen, 2015, Clinical pharmacokinetics of melatonin: A systematic review, Eur. J. Clin. Pharmacol. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Historically, due to the lack of safety data, melatonin supplementation was not recommended for women who are pregnant or nursing.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Similarly, caffeine is also metabolized through CYP1A2 and can increase melatonin levels [305].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [305] Ursing, 2003, Caffeine raises the serum melatonin level in healthy subjects: An indication of melatonin metabolism by cytochrome P450(CYP)1A2, J. Endocrinol. Investig. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It should be noted that studies were of various lengths, with some as short as two weeks, and the longest-lasting study was six months.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Indiscriminate, long-term dosing may lead to unnecessary dependence and even perturbations in puberty onset when nocturnal levels of melatonin tend to decline [291].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [291] Boafo, 2019, Could long-term administration of melatonin to prepubertal children affect timing of puberty? A clinician’s perspective, Nat. Sci. Sleep source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“and in the case of methylcobalamin specifically, may even result in less need for sleep and impart better sleep quality [311]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [311] Mayer, 1996, Effects of vitamin B12 on performance and circadian rhythm in normal subjects, Neuropsychopharmacology source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Other factors: Season, physical activity, age, gender, genetic factors related to the volume of the active pineal gland, and possibly posture at the time of sample collection may all influence melatonin levels [323].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
What the sources say
- Not checked yetcites [323] Rzepka-Migut, B., and Paprocka, J. (2020). Melatonin-Measurement Methods and the Factors Modifying the Results. A Systematic Review of the Literature. Int. J. Environ. Res. Public Health, 17. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, the timing of eating and time of sleep may influence melatonin levels, as can intermittent fasting.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It has been shown to have systemic effects through its mechanisms of action, ultimately having the potential for a significant impact on the etiologies of multiple chronic diseases.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“When worn during a 60 min light pulse at 0100 h, blue-light-blocking glasses resulted in a slight increase in melatonin levels compared to baseline, while melatonin levels decreased significantly by 46% in the control condition [320].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [320] Bennett, 2009, Use of modified spectacles and light bulbs to block blue light at night may prevent postpartum depression, Med. Hypotheses source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“When it comes to supplemental sources, phytomelatonin may have greater efficacy and present a more sustainable, low-toxic option compared with synthetic formats of melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In healthy adults without sleep or circadian disorders, using blue-light-blocking glasses from 1800 h until bedtime for a week resulted in subjective reports of earlier sleep onset, though objective measures were not improved.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“One recent clinical trial in type 2 diabetics found that modest vitamin D supplementation helped to increase both vitamin D and glutathione levels, while decreasing oxidative stress and inflammation [317].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [317] Gu, 2022, Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes, J. Clin. Lab. Anal. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, lifestyle habits such as proper exposure to light and darkness and less blue light at night are also helpful for establishing healthy melatonin levels.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It remains unclear how food intake (types of foods, macronutrient distribution, timing) during the day can alter pineal gland secretion of melatonin at night;”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“After seven nights of wearing blue blockers for two hours before bed, people with insomnia have significantly improved subjective and objective total sleep time, sleep quality, and soundness [321].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [321] Shechter, 2018, Blocking nocturnal blue light for insomnia: A randomized controlled trial, J. Psychiatr. Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From a scientific perspective, melatonin acts as a powerful antioxidant that can cross the blood–brain barrier, inhibit inflammation, and interact with the gut microbiome.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, while not yet extensively researched, there could be an interrelationship between the collective antioxidant activities of glutathione, vitamin D, and melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“For people with Delayed Sleep-Wake Phase, wearing blue-light-blocking glasses from 2100 h to bedtime for two weeks resulted in their dim-light melatonin onset occurring 78 min earlier, while sleep onset was significantly earlier by 132 min [322].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [322] Esaki, 2016, Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial, Chronobiol. Int. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Various research studies have confirmed that there are individual associations between melatonin and glutathione [165], and glutathione and vitamin D [316].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [165] Muñoz-Jurado, A., Escribano, B.M., Caballero-Villarraso, J., Galván, A., Agüera, E., Santamaría, A., and Túnez, I. (2022). Melatonin and multiple sclerosis: Antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology, 1–28. source
- Not checked yetcites [316] Parsanathan, 2019, Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice, Sci. Rep. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“To reduce the risk of inaccuracies, the patient would at least need to abstain from dietary sources of melatonin; however, this is not always practical, and many foods contain melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Routine laboratories do not tend to offer this type of testing, and of the specialty labs that offer these assessments, there are some confounding factors to consider:”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Rests on an assumption: Routine laboratories do not tend to offer melatonin testing.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From a clinical point of view, melatonin imbalance may indicate “darkness deficiency” in much the same way that vitamin D may infer whether or not someone has a “light deficiency”.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Light exposure: Results will be variable and potentially influenced by light conditions. Since melatonin is strongly suppressed by light, the test will not yield many useful data in people’s normal home lighting. It will simply reflect the suppressed levels expected in electric lighting.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The circadian release of melatonin is strongly suppressed by light, particularly blue light.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, melatonin is an intriguing compound, not unlike vitamin D, which is pleiotropic in activity and responsive to light-dark cycles.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. It may state two separate claims as one.
In the paper
“Glutathione is one of the major antioxidant systems in the body and is susceptible to changes in redox status and nutrient supply [315].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [315] Minich, D.M., and Brown, B.I. (2019). A Review of Dietary (Phyto)Nutrients for Glutathione Support. Nutrients, 11. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
Oxidative stress is one of the leading causes of age-related brain dysfunction by impairing neurogenesis.
“Oxidative stress is one of the leading causes of age-related brain dysfunction by impairing neurogenesis.”
The paper relies on this without support.
The purity of a melatonin dietary supplement available to most consumers on the retail store shelf may be debatable or simply unknown without greater diligence to investigate the source.
“Thus, the purity of a melatonin dietary supplement available to most consumers on the retail store shelf may be debatable or simply unknown without greater diligence to investigate the source, which is often cumbersome and time-consuming.”
The paper relies on this without support.
Larger doses of melatonin do not always confer greater health benefits.
“Larger doses do not always confer greater health benefits.”
The paper relies on this without support.
The upper limits of a lethal dose of melatonin have not been clinically established.
“The upper limits of a lethal dose of melatonin have not been clinically established.”
The paper relies on this without support.
Melatonin is quickly broken down by the body.
“Melatonin is quickly broken down by the body and should be dosed at the appropriate, personalized level for each patient.”
The paper relies on this without support.
Melatonin may not be effective for everyone.
“Melatonin may not be effective for everyone but could be well-suited for those individuals with a history of jet lag and/or for those flying across ≥ five time zones to the East [74].”
The paper relies on this without support.
There is some indication that melatonin may be of benefit during pregnancy and nursing.
“However, there is some indication that melatonin may be of benefit during both these stages.”
The paper relies on this without support.
In certain instances, nutrients may be more effective when included with melatonin or vice versa.
“Conversely, in certain instances, nutrients may be more effective when included with melatonin or vice versa.”
The paper relies on this without support.
Type 2 diabetics may be particularly vulnerable to decreases in antioxidants and increases in inflammatory markers.
“Type 2 diabetics may be particularly vulnerable to decreases in antioxidants and increases in inflammatory markers.”
The paper relies on this without support.
The circadian release of melatonin is strongly suppressed by light, particularly blue light.
“The circadian release of melatonin is strongly suppressed by light, particularly blue light.”
The paper relies on this without support.
Assessing one's levels of systemic melatonin is difficult.
“From a clinical perspective, assessing one’s levels of systemic melatonin is difficult.”
The paper relies on this without support.
Routine laboratories do not tend to offer melatonin testing.
“Routine laboratories do not tend to offer this type of testing”
The paper relies on this without support.
Melatonin has been misunderstood as a sleep aid.
“To some extent, melatonin has been misunderstood as a sleep aid.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melatonin acts together with vitamin D as “light sensors” to meet the requirements for light and dark (Minich et al. 2022).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Minich et al. 2022
In the citing paper
“Interestingly, in 2020–2021, during the COVID-19 pandemic period, melatonin was the most sought-after supplement to optimize levels of cytokines linked with disturbed sleeping (Minich et al. 2022).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Minich et al. 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
A 50 km course is labeled as 31 meters
MinorFifty kilometers is 50,000 meters, not 31 meters. The parenthetical appears to mean 31 miles.
Reported 31 · recomputed 50000
“a 50 km (31 m) course”
Citations
Cites
1 retracted
Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1101444 · Cited by 111
RetractedThe National Center for Biotechnology Information
Benson, D. A., Boguski, M. S., Lipman, D. J., & Ostell, J. (1990) · Genomics · doi:10.1016/0888-7543(90)90583-g · Cited by 5,109
Ighodaro, O. M., & Akinloye, O. A. (2017) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 4,036 · cited 2×
“Notably, as stated above, it is a highly efficient antioxidant as one molecule of melatonin can scavenge multiple (~10) reactive oxygen and nitrogen species through a cascading mechanism related to its secondary, tertiary, and even quaternary metabolites [24,31].”
BackgroundInternational Classification of Sleep Disorders-Third Edition
Sateia, M. J. (2014) · Chest · doi:10.1378/chest.14-0970 · Cited by 3,860
Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · cited 3×
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 4), 267–470% more potent free-radical scavenging ability (see Figure 5), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 6) when compared to synthetic melatonin, most likely due to the other constituent…”
BackgroundHealth disorders of shift workers
Knutsson, A. (2003) · Occupational Medicine · doi:10.1093/occmed/kqg048 · Cited by 1,218
Sunlight and Vitamin D: A global perspective for health
Wacker, M., & Holick, M. F. (2013) · Dermato-Endocrinology · doi:10.4161/derm.24494 · Cited by 1,156
Dubbels, R., Reiter, R. J., Klenke, E., Goebel, A., Schnakenberg, E., Ehlers, C., SCHIWARA, H. W., & Schloot, W. (1995) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1995.tb00136.x · Cited by 1,104
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875 · cited 10×
“Production gradually declines as people age, starting in the late twenties to the fifties, with production leveling at approximately 30 pg/mL [4,11] (see Figure 1).”
BackgroundInfluential
Flagged first, then by citations
19 of the 339 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–174 of 174
Fertility under fire: how chemotherapy harms the ovaries and the science fighting back?
Zhou, J., Zhang, D., Yu, Y., & Zhou, Q. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-025-01950-6 · Cited by 5
“Melatonin, a hormone synthesized and secreted by the pineal gland, exhibits a distinct circadian rhythm and is currently utilized in clinical practice for managing insomnia disorders [122, 123].”
Zanirate, G. A., Bressan, J., Leal, A. C. G., Pimenta, A. M., & Hermsdorff, H. H. M. (2026) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70193 · Cited by 4
Zhou, C., Li, X., Xing, C., & Cao, C. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71465 · Cited by 2
“Beyond sleep regulation, studies have also indicated that melatonin possesses significant antioxidant, anti-inflammatory, and immunomodulatory activities (Minich et al. 2022; Reiter et al. 2016; Tan et al. 2015).”
Gao, J. X., Wang, L. H., Li, W., & Liu, W. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2624183 · Cited by 2
“Melatonin is a neurohormone primarily produced by the pineal gland, yet it reaches the testes, crosses the blood–testis barrier, and directly modulates testicular function [101,102].”
Gulothungan, G., Vickram, A. S., & Dhama, K. (2022) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2022.10(5).960.977 · Cited by 2
Yığıt, S., Tural, Ş., Acı, R., & Sezer, Ö. (2023) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20221713 · Cited by 2
Smorodin, E. P., Chuzmarov, V., & Veidebaum, T. (2024) · Current Oncology · doi:10.3390/curroncol31040149 · Cited by 2
“Regarding the effect on sleep and circadian rhythms, effective doses may be less than 2–3 mg/day, as administration of higher doses may cause the desensitization of Mel receptors [113,114].”
BackgroundResearch Progress of Tryptophan and Its Metabolites in the Microbial-Gut-Brain Axis
唐, 婕. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1461901 · Cited by 2
Metabolic syndrome, dyssomnia, and melatonin
Сергієнко, В. О., Sehin, V. B., Hotsko, M. E., Serhiyenko, L. M., & Serhiyenko, O. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.2.2024.1375 · Cited by 2
Low-Dose Interferon I and III-Based Nasal Sprays: A Good-Looking COVID-19 Vaccine Candidate?Preprint
Carp, T.-N., & Metoudi, M. (2022) · Preprints.org · doi:10.20944/preprints202212.0155.v2 · Cited by 1
Carp, T.-N., Metoudi, M., Brown, B., & Ojha, V. (2023) · Preprints.org · doi:10.20944/preprints202212.0155.v4 · Cited by 2
Potential Use of Melatonin in Periodontal Disease
Орлова, С. В., Zyryanov, S. K., Никитина, Е. А., Tigay, Y. O., Orlova, A. A., & Grabovsky, G. A. (2023) · Medical alphabet · doi:10.33667/2078-5631-2023-20-19-29 · Cited by 1
Composition of food supplements containing melatonin available in Portugal
Araújo, B. V., Rato, F., & Capela, J. P. (2025) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902025e24287 · Cited by 1
Association of MTNR1B Gene Polymorphisms with Body Mass Index in Hashimoto’s Thyroiditis
Škrlec, I., Biloglav, Z., Lešić, D., Talapko, J., Žabić, I., & Katalinić, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083667 · Cited by 1
“Melatonin’s protective effect against ROS-induced damage and obesity suggests that melatonin supplementation could be an effective intervention therapy for age-related diseases [79,80].”
Liu, Z., Xie, J., Xiong, M., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118338 · Cited by 1
Rui, H., Xu, X., Song, F., et al. (2025) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2025.104240 · Cited by 1
Chronobiology and Neurodegeneration: The Role of Melatonin in Alzheimer's Disease
Vaja, R., Vohra, M., Ramachandran, A. V., & Baxi, D. B. (2025) · Nutritional Psychiatry · doi:10.1016/j.nupsyc.2025.100001 · Cited by 1
Evaluation of the Vitamin D Effect on Some Blood Parameters
Ozyurt, E., Udum, D., Bulut, S. F., & Yalçın, M. (2025) · Journal of Research in Veterinary Medicine · doi:10.30782/jrvm.1797951 · Cited by 1
Yazıcı, S., Turan, G., Yilmaz, M. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093896 · Cited by 1
“Serotonin receptor activation stimulates mitochondrial biogenesis and homeostasis in renal injury [29], while melatonin exerts anti-inflammatory effects by reducing IL1-alpha, IL1-beta, Mcp-1 and TGF-beta1mRNA levels, thereby mitigating ROS formation, fibrosis, and apoptosis [30–32].”
Effectiveness of Melatonin‐Containing Foods on Promoting Sleep: A Scoping Review
Nisar, T., Fuller, A., Gyawali, P., & Bird, S. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71823 · Cited by 2
“…derived from food sources may range from picograms to milligrams per gram depending on the food matrix and source (Zanirate et al. 2026), whereas supplemental melatonin for adults is commonly recommended at doses of 0.2–5 mg administered approximately 60 min before bedtime (Minich et al. 2022).”
InfluentialMao, Q., Lin, B., Xia, W., Zhang, Y., Lei, Y., Cao, Q., & Xu, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1811583 · Cited by 1
“Apart from regulating sleep rhythms, MT also has anti-in fl ammatory and antioxidant effects (16).”
Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implications
Singh, B., Pigazzani, F., & Manfredini, R. (2026) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70046 · Cited by 4
“Minich et al. 69 introduced the concept of “ darkness de fi ciency, ” in which arti fi cial light exposure suppresses melatonin synthesis in a manner compared with vitamin D de fi ciency caused by inadequate sunlight exposure, potentially further driving circadian imbalance in AD.”
Batarseh, N., Al-Dalaeen, A. M., Abdulla, F. A., & Abdelhadi, N. N. (2026) · Nutrition and Health · doi:10.1177/02601060261477833 · Cited by 1
Political economics in health and implications for neurosurgery diseases
Han, Y., & Huang, Y. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1444249 · Cited by 1
Widespread pain syndrome in long COVID-19: melatonin as an adjuvant treatment
Souissi, A., Prieto-González, P., & Saad, H. B. (2025) · Frontiers in Pain Research · doi:10.3389/fpain.2025.1609095 · Cited by 1
PATHOPHYSIOLOGY OF PLEIOTROPIC EFFECTS AND PROSPECTS FOR THE USE OF MELATONIN
Osikov, M. V., В., Г. И., Ushakova, V. A., et al. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.32443 · Cited by 1
Low-Dose Interferon I and Iii-Based Nasal Sprays: A Good-Looking Covid-19 Vaccine Candidate?Preprint
Carp, T.-N., & Metoudi, M. (2022) · Preprints.org · doi:10.20944/preprints202212.0155.v1
Low-Dose Interferon I and III-Based Nasal Sprays: A Good-Looking COVID-19 Vaccine Candidate?Preprint
Carp, T.-N., Metoudi, M., Brown, B., & Ojha, V. (2023) · Preprints.org · doi:10.20944/preprints202212.0155.v3
Pluta, R. M. (2023) · Nutrients · doi:10.3390/nu15061506 · Cited by 1
“In conclusion, the authors claim that “overall, melatonin is an intriguing compound, not unlike vitamin D, which is pleiotropic in activity and responsive to light-dark cycles” [1].”
BackgroundSingh, V. B., & srivas, S. K. (2023) · Research Square · doi:10.21203/rs.3.rs-3210774/v1
O papel da vitamina D na regulação do ciclo sono-vigília
Moreira, D. J. S., Vasconcelos, S. D. S., de Oliveira, V. F. L., et al. (2023) · Revista Neurociências · doi:10.34024/rnc.2023.v31.15314
Assessment of the Impact of Nutritional Status on the Prognosis of FMF Patients
(2023) · Middle East Journal of Applied Sciences · doi:10.36632/mejas/2023.13.4.37
Xu, S.-H., Zhou, F.-J., Liu, S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4532465/v1
Zhao, Q., Wang, L., Xiang, H., & Qiu, L. (2024) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.24-147
Bruti, G., Giacomo, P. D., Pratesi, A., & Paolo, C. D. (2025) · Cureus · doi:10.7759/cureus.79303
“Interestingly, it has been postulated that, just as melatonin is the hormone of darkness, vitamin D is the hormone of light and that the two act synergistically and reciprocally in regulating multiple systemic functions, including inflammation and immune regulation [30].”
Deng, Y., Shi, B., Qi, Y., Luo, Z., Cui, C., Chen, S., Zhou, X., Zhao, Z., Zhang, X., & Hu, J. (2025) · Animals · doi:10.3390/ani15050682
“Recent studies have shown that MELT is not only a hormone that regulates sleep but also has significant immunomodulatory and anti-inflammatory effects [10].”
孙, 芝. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1571949
The role of antioxidant supplementation in neuronal disorders
ShamsEldeen, A. M., Ammar, H. I., Al-Hashem, F. H., Alrefaie, Z. A., Aly, M. H., & Hanna, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27333-9.00004-x
Nutrition Facts in the Over-Eighty Population: A Narrative Review
Riccio, P., & Jirillo, E. (2025) · Nutrients · doi:10.3390/nu17172740
“There are several similarities between melatonin and vitamin D: both act as hormones, possess immunomodulatory and anti-inflammatory properties, are present in the skin, and respond to environmental light cycles—vitamin D to sunlight, melatonin to darkness [96,97].”
Souissi, A., Abderrahman, A. B., Zemni, B., & Saad, H. B. (2025) · Biological Rhythm Research · doi:10.1080/09291016.2025.2557839
“High doses or prolonged use of melatonin should also be avoided, as the long-term endocrine effects of its administration remain uncertain (Minich et al. 2022).”
Kornfield, M. S., Nielsen, K. R., Fine, G. M., et al. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03643-x
“However, melatonin also appears to have a reproductive function – it has been identified at higher concentrations within mature ovarian follicles and the ampulla of fallopian tubes, the site of fertilization and early embryogenesis [28].”
dos Santos, B. R. R., dos Santos, P. H. F., Araújo, L. G. S., Nobre, I. E. D. S., Costa, J. Y. V., Rabelo, L. A., & Feitoza, C. C. (2025) · Revista de Pesquisa Cuidado é Fundamental Online · doi:10.9789/2175-5361.rpcfo.v17.14086
New galenic formulations of melatonin and therapeutic applications
Serrano, D. R., Torrado, J. J., Öngoren, B., & Anaya, B. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30240-4.00013-2
Mei, H., Zhao, C., Jin, H., Qi, W.-Y., Lu, X., Xin, Y., Wang, W., Sun, Y., & Li, W. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1717587
Bebykh, O. R., & Ivanko, O. V. (2025) · Kharkiv Surgical School · doi:10.37699/2308-7005.5.2025.09
Metabolism of individual amino acids in health and disease
Holeček, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-44534-7.00016-8
Wang, L., Yan, Y., Cao, Q., et al. (2025) · Animal nutrition · doi:10.1016/j.aninu.2025.12.001
Negoro, H., Nakamoto, I., Uiji, S., Matsushima, Y., Mathis, B. J., Kanikowska, D., & Wakamura, T. (2023) · Figshare · doi:10.6084/m9.figshare.24585877
Neuroprotective Potential of Melatonin via ERK1/2 Dependent Nrf2 Activation
Medawaththa, N. S., Raveesha, S., Gonawala, L., & Wijekoon, N. (2026) · Springer eBooks · doi:10.1007/978-981-95-4751-7_7
ROLE OF MELATONIN IN THE MANAGEMENT OF SLEEP DISORDERS IN SCHIZOPHRENIA: A LITERATURE REVIEW
Wydrych, A., Pindlowski, P., Wietrzykowska, E., Trojan, P., Kuklo, M., Karolak, A., Karasiewicz, A., Kras, M., Tomczyk, A., & Olkowski, M. S. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4153
Chen, Z., Chen, Z., Peng, L., & Zhang, H. (2026) · Mediators of Inflammation · doi:10.1155/mi/4659271
Autophagy in neuropathic pain: Cell specificity, molecular mechanisms, and therapeutic prospects
Fu, L., Yang, Y., Ma, Y., Wang, Y.-H., Tang, P. C., & Liu, J. (2026) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2026.02.008 · Cited by 1
Unveiling the Anti-Aging Potential of Topical Melatonin: A Systematic Review
Budiono, C. A., Anwar, A. I., Madjid, A., Djawad, K., Zainuddin, A. A., & Rahman, L. (2026) · SKIN The Journal of Cutaneous Medicine · doi:10.25251/rf89pa05
Vieira-Brinker, A., Wolfson, A., Venta, A., & Alfano, C. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.108938
Shekh, R. S., & Maulood, I. M. (2026) · Polytechnic Journal · doi:10.59341/2707-7799.1873
Circadian misalignment in PCOS: role of sleep and light
Samaddar, S., Ghosh, S., Kumar, A., Yadav, P., Yadav, M., & Dahiya, R. (2026) · Biological Rhythm Research · doi:10.1080/09291016.2026.2651558 · Cited by 2
“The antioxidant action of melatonin is also able to counteract oxidative stress, which is a key player in ovarian dysfunction in PCOS (Minich et al. 2022).”
Zhang, X., Ouyang, M., Wu, X., et al. (2026) · doi:10.2196/preprints.100064
Ulusu, N. N. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1813234
Vaja, R., Ramachandran, A. V., & Baxi, D. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112139
Trucillo, P., Ielpo, M., Liuzzi, A., et al. (2026) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2026.107039
Garbarek, J., Markiel, J., Rzepka, W., et al. (2026) · Molecules · doi:10.3390/molecules31101767
Qiu, S.-Y., Cai, S., Xie, R., Liu, C., & He, Y.-Z. (2026) · Journal of Pineal Research · doi:10.1111/jpi.70154
Yang, Q., Lu, X., 路亚枫, et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06146-4
Non-pharmacological correlates of insomnia among university lecturers in Nigeria
Ogabor, J. O., Osaji, N., Apie, M. A., Mohammed, S., Essien, E. S., Ukpata, C. O., Odok, E. A., Udida, J. U., Ogar, E., Eyam, D. E., et al. (2026) · Discover Public Health · doi:10.1186/s12982-026-02454-4
“Natural dietary sources of melatonin and tryptophan, including tart cher-ries, nuts, seeds, legumes and selected fruits, are associated with improvements in sleep onset and continuity through serotonergic and circadian pathways [17, 68, 95].”
Melatonin in the Context of Women's Health
Nikolaeva, M. G., Uvarova, Y. M., & Горбачева, Т. И. (2026) · ASTRAKHAN MEDICAL JOURNAL · doi:10.17021/1992-6499-2026-1-27-33
Lv, H., Jiang, X., Zhang, W., Kan, S., Zhang, Y., Wang, B., Peng, F., & Yu, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1877824
“It is involved in diverse physiological processes, including the regulation of sleep–wake cycles, antioxidant defense, immunomodulation, and tumor suppression (Minich et al., 2022; Ahmad et al., 2023; Joseph et al., 2024; Reiter et al., 2024).”
Zolubaite, M., Mekouar, Z. M., & Barrow, M. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115484
Melatoninin Kanser Gelişiminde ve Tedavisinde Antioksidan Rolü
Kahveci, E., Tengiz, F. İ., & Soyöz, M. (2026) · Izmir Katip Celebi University Faculty of Medicine · doi:10.52818/cjmr.1687939
Molano, J. R. V. (2026) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2026.07.007
Hosseinzadeh, P., Mohammadipour, A., Sajjadi, S. M., Hosseini, M., & Rastegar-Moghaddam, S. H. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e45428
Prognostic value of melatonin-related signature genes in lung adenocarcinoma
Guo, H., Liu, L., Lu, Y., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0357584
Zhang, X., Ouyang, M., Wu, X., Yang, X.-H., Wang, X., Cao, Y., Xu, M., Shu, Y., & Wu, M. (2026) · JMIR mhealth and uhealth · doi:10.2196/100064
Haskologlu, I. C., & Özünal, Z. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198473
Aydın, N. E., Özden, K., Kırkpunar, A., & Çeti̇ner, S. (2026) · Biomedicines · doi:10.3390/biomedicines14102204
Metadata
- Authors
- Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J.
- Affiliations
- University of Western States (US)
- University of the Rockies (US)
- National University of Natural Medicine (US)
- Bastyr University (US)
- School of Nutrition, Sonoran University of Health Sciences, Tempe, AZ 85282, USA
- Natural Health International Pty., Ltd., Sydney, NSW 2000, Australia
- Corresponding author
- Minich, Deanna M.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-09-22
- Volume
- 14
- Issue
- 19
- Pages
- 3934
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC9571539
- OpenAlex
- W4296829676
- Semantic Scholar
- e2efdb871a3ef1f27a752431bf3a072a4deb68ea
- Cited by
- 176
- References
- 339
- Citations by year
- 2026: 39 · 2025: 63 · 2024: 37 · 2023: 34 · 2022: 3
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Symphony Natural Health
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melatonin, dietary supplements, sleep, antioxidant activity, immunomodulation, anti-inflammatory activity, mitochondrial regulation, vitamin D, blue light exposure, melatonin deficiency, supplement safety, phytomelatonin, Alzheimer's disease, cancer, multiple sclerosis, polycystic ovary syndrome, fertility, COVID-19 pandemic
- MeSH terms
- COVID-19, Animals, Antioxidants, Circadian Rhythm, Humans, Melatonin, Vitamin D, Vitamins, Dietary Supplements, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review